ABCB1 and ovarian cancer: Targeted regulation of ABCB1 expression can sensitize ovarian cancer cells to paclitaxel and cisplatin, providing an effective treatment option for patients with chemoresistant ovarian cancer (Sun et al., 2015; Vaidyanathan et al., 2016).